Skip to main content
OpenTrials
Completed

NCT Number: NCT04962373

Brief Admission for Adolescents Who Self-harm

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). The characteristics of BA is different from other types of admission, being focused on prevention through increased autonomy and self-care, based on structured and voluntary brief self-referrals to hospital (3). As a result of a randomized controlled trial, BA is since January 2019, continuously offered to adults with self-harm at risk for suicide in Skåne (4). Parallel to this clinical trial, the method has been adapted to work in a psychiatric setting for adolescents. At present 24 adolescents have access to the method in Skåne. Clinical experiences from staff are promising, however, the lived experiences have not been collected in a standardized way.

The aim of the present study is to gather information on how BA in its present, standardized form works for adolescents, their loved ones and staff working at the ward providing BA. This will be done through semi-structured interviews with:

1. Adolescents using BA and their loved ones 2. Staff working at the ward providing BA. Data will be analyzed with qualitative analysis (5, 6). The ultimate aim is to use these results to optimize the current standardized version of BA for adolescents in order to test in a randomized clinical trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Psykiatri och habilitering, Region Skåne

Lund, Skåne County, 22185, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Sample 1:

Inclusion criteria

  • Adolescents with an active BA contract
  • At least 13 years of age.
  • Able to consent to study participation through written and oral information.
  • Consent from caregivers
  • Given consent to participate

Exclusion criteria

  • Below the age of 13.

Sample 2:

Inclusion criteria

  • Parents to adolescents with an active BA contract
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate

Exclusion criteria

  • None

Sample 3:

Inclusion criteria

  • Staff working with adolescents with an active BA contract
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate

Exclusion criteria

  • None

Treatment and study plan

semi-structured interviews

Other

Each participant will attend a 30-60 minute semi-structured interview conducted by the CI

Primary outcomes

  1. Perceived effective components of Brief Admission for adolescents

    Time frame: 60mins

    Qualitative data from interviews

  2. Potential adaptations of the method to better fit adolescents

    Time frame: 60mins

    Qualitative data from interviews

  3. Areas where Brief Admission have the most prominent perceived effects in adolescents

    Time frame: 60mins

    Qualitative data from interviews

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Collaborators

  • Lund University

Registry information

Official study title

Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention

Important dates

Study start
2020
Primary completion
2025
Study completion
2025
First posted
Jul 15, 2021
Registry last updated
Aug 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.